Fominoben

Fominoben is a pharmaceutical drug that has been used in the treatment of various medical conditions. It is classified under the category of non-steroidal anti-inflammatory drugs (NSAIDs), which are commonly used to reduce inflammation, relieve pain, and decrease fever.
Mechanism of Action[edit]
Fominoben works by inhibiting the activity of cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2. These enzymes are responsible for the synthesis of prostaglandins, which are lipid compounds that play a key role in the inflammatory response. By blocking the production of prostaglandins, Fominoben helps to alleviate symptoms associated with inflammation and pain.
Indications[edit]
Fominoben is indicated for the treatment of:
- Rheumatoid arthritis
- Osteoarthritis
- Ankylosing spondylitis
- Acute pain conditions such as musculoskeletal injuries and postoperative pain
Side Effects[edit]
Common side effects of Fominoben may include:
Serious side effects, although rare, can include:
- Gastrointestinal bleeding
- Kidney dysfunction
- Liver toxicity
- Cardiovascular events such as heart attack and stroke
Contraindications[edit]
Fominoben should not be used in individuals with:
- Known hypersensitivity to Fominoben or other NSAIDs
- History of peptic ulcer disease or gastrointestinal bleeding
- Severe renal impairment
- Severe hepatic impairment
- Pregnancy and breastfeeding without medical advice
Dosage and Administration[edit]
The dosage of Fominoben should be individualized based on the patient's condition and response to therapy. It is typically administered orally, with or without food. The recommended starting dose for adults is usually between 100 mg to 200 mg per day, divided into two or three doses.
Pharmacokinetics[edit]
Fominoben is well-absorbed from the gastrointestinal tract, with peak plasma concentrations occurring within 1 to 2 hours after oral administration. It is extensively metabolized in the liver and excreted primarily in the urine.
Research and Development[edit]
Ongoing research is being conducted to explore the potential of Fominoben in treating other inflammatory conditions and to better understand its safety profile.
See Also[edit]
References[edit]
External Links[edit]
-
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian